Change control in medtech: classifying design and process changes

Change control keeps devices safe and documentation coherent as products evolve. The first question is classification: did we change design or components, a manufacturing process or site, labeling or claims, or software, firmware, or a model? Then: did intended use move, and could residual risk increase?

Worked example. A Class II wearable updates its photoplethysmography firmware to improve motion filtering. Intended use and indications are unchanged. Bench checks show smaller bias and variance, and verification passes. Risk impact is unchanged or reduced. Document the design and software change. Follow the FDA software-change flowchart. A new 510(k) is not the default if no new risks or worse performance are introduced, but the rationale belongs in the file.

Common mistakes. Treating a labeling tweak as purely marketing, when claims are part of intended use. Skipping a look at the accumulated changes, because small steps can add up to a new question of safety or effectiveness. Calling information-for-safety a control when a practical design fix exists.

Use the change-control classifier: https://nexamedtech.com/tools/change-control